Haematology

New blood cancer therapies bring new hope

Professor Michael O’Dwyer, Director of Blood Cancer Network Ireland and Professor of Haematology, speaks about the exciting new therapies for Irish blood cancer patients.

Getting new drugs to patients faster through clinical trials

Professor Michael O’Dwyer is director of Blood Cancer Network Ireland (BCNI), which aims to facilitate patient access to innovative blood cancer therapies through participation in early stage, or Phase I, clinical trials.

Outlook for blood cancer patients improves

Every year, around 1,500 people in Ireland are diagnosed with blood cancer – an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.

Investments and collaboration bring more hope for patients

Research investments and collaborative efforts aimed at improving treatment choice, public awareness is driving Irish blood cancer patients towards a more positive future.